{
    "identity": "nprot-7291",
    "title": "Protocol for CRISPR/Cas9-based knock-in using the VIKING method",
    "content": [
        {
            "header": "Reagents",
            "content": "**Cell culture reagents** \r\n\n\nDulbecco's modified Eagle's medium \\(043-30085; Wako, Osaka, Japan)\r\n\n\nFetal Bovine Serum, Irish Origin \\(S1780-500; Biowest, Nuaille, France)\r\n\n\nPenicillin-Streptomycin-Amphotericin B Suspension \\(\u00d7100) \\(Antibiotic-Antimycotic Solution) \\(161-23181; Wako)\r\n\n\nPhosphate-buffered saline. \\(164-25511; Wako, Osaka, Japan)\r\n\n\nTrypsin \\(201-16945; Wako, Osaka, Japan)\r\n\n\n\r\n\n\n**Transfection**\r\n\n\nOpti-MEM\u2122 I Reduced Serum Medium, no phenol red \\(11058-021; Life Technologies, California, USA)\r\n\n\nTurboFect transfection reagent \\(R0531; Thermo Fisher Scientific, Waltham, MA)\r\n\n\nPuromycin dihydrochloride \\(P8833; Sigma-Aldrich Japan, Tokyo, Japan)\r\n\n\nBlasticidin S, Hydrochloride \\(KK-400; Kaken Pharmaceutical, Tokyo, Japan)\r\n\n\n\r\n\n\n**Plasmids**\r\n\n\nTarget genome cleavage vector \\(we use pX330*; https://www.addgene.org/42230/) \\(Fig. 1a blue)\r\n\n\nAAVS1 locus-specific cleaving vector \\(see Remark 1) \\(Fig. 2 blue)\r\n\n\nDonor vector* \\(pVKG1-PURO, Puromycin resistance, or pVKG1-BSD, Blasticidin resistance, which are distributed by Addgene \\(108670 and 108680, respectively)) \\(Fig. 1a magenta)\r\n\n\nFLAG-tagged VDR variant \\(Gln259 > Pro) expression vector \\(pcDNA3- FLAGhVDRQ259P****)\r\n\n\nDonor cleavage vector***** \\(VKG1-gRNA-pX330, which is distributed by Addgene \\(108671)) \\(Fig. 1a green)\r\n\n\n*A human codon-optimized SpCas9 and chimeric guide RNA expression plasmid.\r\n\n\n****This pCDNA3 backbone contains a VKG1 sequence for cleavage by Cas9-gRNA.\r\n\n\n*****The donor cleavage and donor vectors are called the VIKING module and do not need to be modified according to the target sequence.\r\n\n\n\r\n\n\n**DNA extraction**\r\n\n\nDulbecco\u2019s phosphate-buffered saline\r\n\n\n50 mM NaOH\r\n\n\n1 M Tris HCl, pH 8.0\r\n\n\n\r\n\n\n**Genotyping**\r\n\n\nGoTaq Polymerase \\(M3001; Promega, Wisconsin, USA)\r\n\n\nPrimers \\(change according to the target locus for knock-in)\r\n\n\nVKG 1_4561 F, 5'-GCCTATGGAAAAACGCCAGC-3'\r\n\n\nVKG 1_250 R, 5'-TTCCTGTCTAGCGGTACGCG-3'\r\n\n\nVDR genome_del 3 F, 5'-GGTGGGCCTCATGTCTTCTG-3'\r\n\n\nVDR genome_del 1 R, 5'-CCTTCATCATGCCGATGTCC-3'\r\n\n\npEN_ObLi_40_For, 5'-TACCGCCTTTGAGTGAGCTG-3'\r\n\n\npEN_ObLi_190_Rev, 5'-AAACCTGTCGTGCCAGCTGC-3'\r\n\n\nAAVS _ F5, 5'-GGAAATGGGGGTGTGTCACC-3'\r\n\n\nAAVS_R6, 5'-CCCTACCCCCCTTACCTCTC-3'"
        },
        {
            "header": "Equipment",
            "content": "Cell culture incubator \\(5% CO<sub>2</sub>/37\u2103)\r\n\n\nBSL-2 biosafety cabinet\r\n\n\n1.5, 15, and 50 mL tubes\r\n\n\nCell culture plasticware \\(e.g., dishes, plates, and pipettes)\r\n\n\nElectroporator \\(CUY21 EDITII; Bex, Tokyo, Japan)\r\n\n\nCloning ring \\(AS ONE, Osaka, Japan)\r\n\n\nAgarose gel electrophoresis equipment\r\n\n\nPCR thermal cycler"
        },
        {
            "header": "Procedure",
            "content": "**Protocol I: Procedure for knock-in/knock-out in cultured cells using the VIKING method**\r\n\n\n**Day 1: Cell culture**\r\n\n\n \u2022  Incubate HaCaT or human embryonic kidney 293F \\(HEK293F) cells in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1 U/mL penicillin-streptomycin \\(D10 medium).\r\n\n\n\\(see Remark 2).\r\n\n\n\r\n\n\n**Day 2: Transfection \\(Fig. 1a)**\r\n\n\n- Electroporation method \\(HaCaT cells)\r\n\n\n \u2022  Suspend cells in 400 \u00b5L Opti-MEM.\r\n\n\n \u2022  Transfect cells with the VIKING module and the target genome cleavage vector using a total of 15 \u00b5g DNA \\(molar ratio of donor cleavage vector \\(VKG1-gRNA-pX330):donor vector \\(pVKG1-PURO):target genome cleavage vector \\(pX330) = 1:1:17) using an electroporator.\r\n\n\n \u2022  Transfer cells to 100 mm dishes and culture in D10 medium lacking antibiotics for 24 h.\r\n\n\n- Lipofection method \\(HEK293F cells).\r\n\n\n \u2022  Suspend cells in 400 \u00b5L Opti-MEM.\r\n\n\n \u2022  Transfect cells with the VIKING module and the target genome cleavage vector using a total of 15 \u00b5g DNA \\(molar ratio of donor cleavage vector \\(VKG1-gRNA-pX330):donor vector \\(pVKG1-PURO):target genome cleavage vector \\(pX330) = 1:1:17) using TurboFect transfection reagent.\r\n\n\n \u2022  Transfer cells to 100 mm dishes and culture in D10 medium lacking antibiotics for 24 h.\r\n\n\n \\(see Remark 3).\r\n\n\n\r\n\n\n**Day 4: Selection**\r\n\n\n \u2022  Refresh D10 medium.\r\n\n\n \u2022  Add puromycin \\(0.3 \u00b5g/mL) to the D10 medium and culture cells for 1\u20132 weeks.\r\n\n\n\r\n\n\n**Day 14: Clone picking \\(Fig. 1b)**\r\n\n\n \u2022  Wash cells with phosphate-buffered saline.\r\n\n\n \u2022  Place the cloning ring on a single colony. Pick at least 20 colonies. Limiting dilution is also possible\uff0e\r\n\n\n \u2022  Add 20 \u00b5L trypsin to each ring.\r\n\n\n \u2022  Incubate cells at 37\u00baC for 2 min \\(HEK293F cells) or 10 min \\(HaCaT cells).\r\n\n\n \u2022  Transfer cells to a 24-well or 48-well plate.\r\n\n\n \u2022  Incubate cells at 37\u00baC for several days.\r\n\n\n \u2022  Transfer cells to a 12-well plate and incubate.\r\n\n\n \u2022  Isolate a portion of the cells for DNA extraction.\r\n\n\n\r\n\n\n**Day 16: DNA extraction**\r\n\n\n \u2022  Add 180 \u00b5L of 50 mM NaOH and transfer to a 1.5 \u00b5L tube.\r\n\n\n \u2022  Incubate at 95\u00baC for 30 min.\r\n\n\n \u2022  Add 20 \u00b5L of 1 M Tris HCl, pH 8.0.\r\n\n\n \u2022  Centrifuge at 12,000 rpm for 10 min.\r\n\n\n \u2022  Transfer the supernatant to a new tube.\r\n\n\n\r\n\n\n**Day 17: Genotyping \\(confirmation of knock-in by PCR) \\(Fig. 1c)**\r\n\n\nKnock-in and random insertion are confirmed by PCR using the extracted DNA as a template \\(see Remark 4 and 5). \r\n\n\nThere is no need for a special polymerase.\r\n\n\nGoTaq polymerase is used in this protocol.\r\n\n\n- Design primers to amplify the VKG1 sequence.\r\n\n\nExample:\r\n\n\nPrimer 1 \\(VKG 1_4561 F), 5'-GCCTATGGAAAAACGCCAGC-3'.\r\n\n\nPrimer 2 \\(VKG 1_250 R), 5'-TTCCTGTCTAGCGGTACGCG-3'.\r\n\n\n- Design primers that specifically bind to the target genome sequence.\r\n\n\nExample:\r\n\n\nPrimer 3 \\(VDR genome_del 3 F), 5'-GGTGGGCCTCATGTCTTCTG-3'.\r\n\n\nPrimer 4 \\(VDR genome_del 1 R), 5'-CCTTCATCATGCCGATGTCC-3'.\r\n\n\n\r\n\n\n**Genotyping by PCR**\r\n\n\n \u2022 PCR sample\r\n\n\n2\u00d7 GoTaq GreenMaster Mix, 12.5 \u00b5L\r\n\n\n10 \u00b5M Primer A, 2.5 \u00b5L\r\n\n\n10 \u00b5M Primer B, 2.5 \u00b5L\r\n\n\nNuclease-free water, 6.5 \u00b5L\r\n\n\nGenomic DNA, 1 \u00b5L\r\n\n\nTotal, 25 \u00b5L\r\n\n\n \u2022 Thermocycle\r\n\n\n95\u00baC for 2 min.\r\n\n\n30 cycles of 95\u00b0C for 30 sec, 55\u00b0C for 1 min, and 72\u00b0C for 2 min.\r\n\n\n72\u00baC for 4 min.\r\n\n\n12\u00baC hold.\r\n\n\nStep 1. Confirm random insertion.\r\n\n\nPCR is performed using Primer 1 and Primer 2 for Amplicon1.\r\n\n\nRandom insertion is confirmed by amplification of Amplicon1.\r\n\n\nStep 2. Confirm knock-in at the target locus.\r\n\n\n- Forward direction\r\n\n\nPCR is performed using Primer 1 and Primer 3 for Amplicon2, or Primer 2 and Primer 4 for Amplicon3.\r\n\n\nKnock-in in the forward direction is confirmed by amplification of Amplicon2 and Amplicon3.\r\n\n\n- Reverse direction\r\n\n\nPCR is performed using Primer 2 and Primer 3 for Amplicon4, or Primer 1 and Primer 4 for Amplicon5.\r\n\n\nKnock-in in the reverse direction is confirmed by amplification of Amplicon4 and Amplicon5.\r\n\n\n\r\n\n\n**Protocol II: Procedure for knock-in in cultured cells using the VIKING method \\(Fig. 2)**\r\n\n\n**Day 1\u201316**\r\n\n\nSame as Protocol I.\r\n\n\n\r\n\n\n**Day 17: Genotyping**\r\n\n\n- Design primers to amplify the VKG1 sequence.\r\n\n\nSame as Protocol I.\r\n\n\n- Design primers to amplify the VKG1 sequence.\r\n\n\nExample:\r\n\n\nPrimer 1 \\(pEN_ObLi_40_For), 5'-TACCGCCTTTGAGTGAGCTG-3'.\r\n\n\nPrimer 2 \\(pEN_ObLi_190_Rev), 5'-AAACCTGTCGTGCCAGCTGC-3'.\r\n\n\n- Design primers that specifically bind to the target genome sequence.\r\n\n\nExample:\r\n\n\nPrimer 3 \\(AAVS_F5), 5'-GGAAATGGGGGTGTGTCACC-3'.\r\n\n\nPrimer 4 \\(AAVS_R6), 5'-CCCTACCCCCCTTACCTCTC-3'.\r\n\n\n\r\n\n\n**Genotyping by PCR**\r\n\n\nSame as Protocol I. \r\n\n\n\r\n\n\n**Remarks**\r\n\n\n1. This vector is selected according to the target locus for knock-in.\r\n  2. In addition to HaCaT and HEK293F cells, the VIKING method has been validated in the C4-2 \\(human prostate cancer), UMR-106 \\(rat osteogenic), and MC3T3-E1 \\(mouse preosteoblastic) cell lines. 3. These two transfection methods are examples and should be changed depending on cell lines to attain a high transfection efficiency.\r\n  4. The backbone of the donor vector is integrated into the genome in principle.\r\n  5. Tandem insertions of the donor vectors sometimes occur."
        },
        {
            "header": "Anticipated Results",
            "content": "Establishment of a deleterious variant of VDR-expressing cell line as an example was demonstrated by using this protocol \\(Fig. 3). VDR knock-out cells were produced using knock-in-mediated gene disruption. Subsequently, VDR variant-expressing cell lines were established by following knock-in of VDR point mutant \\(Q259P) vector into a safe harbor site of these VDR-knock-out HaCaT cells \\(Fig. 3a). Immunoblot results were shown the VDR deficiency in VDR knock-out cells and the expression of VDR variant in the knock-in cells \\(Fig. 3c)."
        }
    ],
    "attributes": {
        "acceptedTermsAndConditions": true,
        "allowDirectSubmit": true,
        "archivedVersions": [],
        "articleType": "Method Article",
        "associatedPublications": [
            {
                "doi": "10.1038/s41598-017-18911-9",
                "date": "2019-01-22 08:13:58",
                "title": "Development of versatile non-homologous end joining-based knock-in module for genome editing",
                "authors": [
                    "Shun Sawatsubashi",
                    "Yudai Joko",
                    "Seiji Fukumoto",
                    "Toshio Matsumoto",
                    "and Shigeo S. Sugano"
                ],
                "journal": "Scientific Reports",
                "logo": ""
            }
        ],
        "authors": [
            {
                "id": 16168,
                "identity": "a1aa7b42-516f-11e9-9e20-12b504df345a",
                "order_by": 0,
                "name": "Shigeo S.  Sugano",
                "email": "shigeohu@gmail.com",
                "orcid": "",
                "institution": "R-GIRO, Ritsumeikan University",
                "correspondingAuthor": true,
                "prefix": "",
                "firstName": "Shigeo",
                "middleName": "S.",
                "lastName": "Sugano",
                "suffix": ""
            },
            {
                "id": 16171,
                "identity": "a1aa8069-516f-11e9-9e20-12b504df345a",
                "order_by": 0,
                "name": "Shun  Sawatsubashi",
                "email": "shun-sawa2@umin.ac.jp",
                "orcid": "",
                "institution": "Department of Molecular Endocrinology, Tokushima University",
                "correspondingAuthor": true,
                "prefix": "",
                "firstName": "Shun",
                "middleName": "",
                "lastName": "Sawatsubashi",
                "suffix": ""
            },
            {
                "id": 16167,
                "identity": "a1aa72bf-516f-11e9-9e20-12b504df345a",
                "order_by": 1,
                "name": "Yudai Joko",
                "email": "",
                "orcid": "",
                "institution": "Department of Molecular Endocrinology, Tokushima University",
                "correspondingAuthor": false,
                "prefix": "",
                "firstName": "Yudai",
                "middleName": "",
                "lastName": "Joko",
                "suffix": ""
            },
            {
                "id": 16169,
                "identity": "a1aa7d3f-516f-11e9-9e20-12b504df345a",
                "order_by": 1,
                "name": "Seiji Fukumoto",
                "email": "",
                "orcid": "",
                "institution": "Department of Molecular Endocrinology, Tokushima University",
                "correspondingAuthor": false,
                "prefix": "",
                "firstName": "Seiji",
                "middleName": "",
                "lastName": "Fukumoto",
                "suffix": ""
            },
            {
                "id": 16170,
                "identity": "a1aa7eed-516f-11e9-9e20-12b504df345a",
                "order_by": 1,
                "name": "Toshio  Matsumoto",
                "email": "",
                "orcid": "",
                "institution": "Department of Molecular Endocrinology, Tokushima University",
                "correspondingAuthor": false,
                "prefix": "",
                "firstName": "Toshio",
                "middleName": "",
                "lastName": "Matsumoto",
                "suffix": ""
            }
        ],
        "badges": [],
        "createdAt": "2019-01-22 10:20:02",
        "currentVersionCode": 1,
        "declarations": "",
        "doi": "10.1038/protex.2019.010",
        "doiUrl": "https://doi.org/10.1038/protex.2019.010",
        "draftVersion": [],
        "editorialEvents": [],
        "editorialNote": "",
        "failedWorkflow": [],
        "files": [
            {
                "id": 2610332,
                "identity": "bd9ac988-65c2-448b-9f17-a6819c964691",
                "added_by": "29b0f50f-991e-4cf6-96fc-2c41c75f34f2",
                "created_at": "2020-09-25 20:51:35",
                "extension": "pdf",
                "order_by": 1,
                "title": "Figure 1",
                "display": "",
                "copyAsset": false,
                "role": "figure",
                "size": 467979,
                "visible": true,
                "origin": "",
                "legend": "Workflow of VIKING method. Schematic image of electrophoresis shows typical results of genotyping (Protocol I).    <a href=\"http://url/for/the/fullsize/image\" > <img src=\"http://www.nature.com/protocolexchange/system/uploads/7477/original/Figure_1.pdf?1548150775/for/the/thumbnail/image\" > </a>",
                "description": "",
                "filename": "figure1.pdf",
                "url": "https://assets.researchsquare.com/files/nprot-7291/v1/figure_1.pdf"
            },
            {
                "id": 2610335,
                "identity": "133ce84d-37ec-4771-9f01-600f68082cb5",
                "added_by": "29b0f50f-991e-4cf6-96fc-2c41c75f34f2",
                "created_at": "2020-09-25 20:51:35",
                "extension": "pdf",
                "order_by": 2,
                "title": "Figure 2",
                "display": "",
                "copyAsset": false,
                "role": "figure",
                "size": 348515,
                "visible": true,
                "origin": "",
                "legend": "Schematic diagram of protocol for knock-in in cultured cells using the VIKING method. (Protocol II)   <a href=\"http://url/for/the/fullsize/image\" > <img src=\"http://www.nature.com/protocolexchange/system/uploads/7479/original/Figure_2.pdf?1548150841/for/the/thumbnail/image\" > </a>",
                "description": "",
                "filename": "figure2.pdf",
                "url": "https://assets.researchsquare.com/files/nprot-7291/v1/figure_2.pdf"
            },
            {
                "id": 2610337,
                "identity": "23703827-af83-4de6-bfad-6be73e02c822",
                "added_by": "29b0f50f-991e-4cf6-96fc-2c41c75f34f2",
                "created_at": "2020-09-25 20:51:35",
                "extension": "pdf",
                "order_by": 3,
                "title": "Figure 3",
                "display": "",
                "copyAsset": false,
                "role": "figure",
                "size": 568826,
                "visible": true,
                "origin": "",
                "legend": "Knock-in of a VDR variant (Q259P) in VDR-knock-out HaCaT cells using the VIKING method.   <a href=\"http://url/for/the/fullsize/image\" > <img src=\"http://www.nature.com/protocolexchange/system/uploads/7481/original/Figure_3_SS.pdf?1548150885/for/the/thumbnail/image\" > </a>",
                "description": "",
                "filename": "figure3.pdf",
                "url": "https://assets.researchsquare.com/files/nprot-7291/v1/figure_3.pdf"
            },
            {
                "id": 13466660,
                "identity": "24a20153-00a3-46bf-8852-c15eb6976888",
                "added_by": "auto",
                "created_at": "2021-09-16 20:51:53",
                "extension": "pdf",
                "order_by": 0,
                "title": "",
                "display": "",
                "copyAsset": false,
                "role": "manuscript-pdf",
                "size": 330398,
                "visible": true,
                "origin": "",
                "legend": "",
                "description": "",
                "filename": "manuscript.pdf",
                "url": "https://assets.researchsquare.com/files/nprot-7291/v1/02ef9908-6619-4a90-aebb-8d693c059e6f.pdf"
            }
        ],
        "financialInterests": "S.S. and S.S.S. have financial interests in Setsuro Tech Inc. A patent has been filed on behalf of S.S. and S.S.S. by Tokushima University.",
        "fulltextSource": "",
        "fullText": "",
        "funders": [],
        "hasOptedInToPreprint": true,
        "hasPassedJournalQc": "",
        "hideJournal": true,
        "highlight": "",
        "institution": "",
        "isAuthorSuppliedPdf": false,
        "isDeskRejected": "",
        "isHiddenFromSearch": false,
        "isInQc": false,
        "isInWorkflow": false,
        "journal": {
            "display": true,
            "email": "protocol.exchange@nature.com",
            "identity": "protocol-exchange",
            "isNatureJournal": false,
            "hasQc": false,
            "allowDirectSubmit": true,
            "externalIdentity": "",
            "sideBox": "",
            "submissionUrl": "https://protocolexchange.researchsquare.com/submission",
            "title": "Protocol Exchange",
            "twitterHandle": ""
        },
        "keywords": "CRISPR, gene targeting, knock-in, knock-out, VIKING, cell culture",
        "license": {
            "name": "CC BY 4.0",
            "url": "https://creativecommons.org/licenses/by/4.0/"
        },
        "manuscriptAbstract": "CRISPR/Cas9-based genome editing has dramatically accelerated genome engineering. We recently developed the versatile non-homologous end joining-based knock-in module for genome editing \\(VIKING) method1. In this method, cells are simultaneously transfected with three vectors \\(donor vector, donor cleavage vector, and target cleavage vector). The VIKING method uses the \u201cVKG1 sequence\u201d which avoids the need for customization of the donor vector. This method has the following three advantages:\r\n\n\n1. The donor and donor cleavage vectors do not need to be modified if they contain the VKG1 sequence. Various vectors \\(such as pUC19, pcDNA3, pENTR/D-TOPO) contain this sequence. By contrast, other techniques involve the design and construction of new donor vectors, which is complicated.\r\n  2. We optimized vector transfection for non-homologous end joining repair-dependent knock-in. Other technologies are hampered by random integration.\r\n  3. DNA sequences longer than 10 kbp can be inserted using the VIKING method. Therefore, a longer sequence can be inserted using this method than using a viral vector. \r\n  Here, we describe the knock-in/knock-out and knock-in procedures using the VIKING method.",
        "manuscriptTitle": "Protocol for CRISPR/Cas9-based knock-in using the VIKING method",
        "msid": "",
        "msnumber": "",
        "nonDraftVersions": [
            {
                "code": 1,
                "date": "2019-01-24 16:32:45",
                "doi": "10.1038/protex.2019.010",
                "editorialEvents": [
                    {
                        "type": "communityComments",
                        "content": 0
                    }
                ],
                "status": "published",
                "journal": {
                    "display": true,
                    "email": "info@researchsquare.com",
                    "identity": "researchsquare",
                    "isNatureJournal": false,
                    "hasQc": true,
                    "allowDirectSubmit": true,
                    "externalIdentity": "",
                    "sideBox": "",
                    "submissionUrl": "/submission",
                    "title": "Research Square",
                    "twitterHandle": "researchsquare"
                }
            }
        ],
        "origin": "",
        "ownerIdentity": "a1a9fa47-516f-11e9-9e20-12b504df345a",
        "owner": [],
        "postedDate": "January 24th, 2019",
        "published": true,
        "revision": "",
        "status": "posted",
        "subjectAreas": [
            {
                "id": 4497,
                "name": "Biological techniques"
            },
            {
                "id": 4499,
                "name": "Genetics"
            }
        ],
        "tags": [],
        "versionOfRecord": [],
        "versionCreatedAt": "2019-01-24 16:32:45",
        "video": "",
        "vorDoi": "",
        "vorDoiUrl": "",
        "workflowStages": []
    }
}